These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 30032892

  • 21. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F.
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [Abstract] [Full Text] [Related]

  • 22. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W, Reiner T, Khuenl-Brady KS.
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [Abstract] [Full Text] [Related]

  • 23. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P, Tonetti T, Barbieri S, Frigo AC, Ori C.
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [Abstract] [Full Text] [Related]

  • 24. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 25. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R, Fülesdi B, Pongrácz A, Asztalos L, Szabó-Maák Z, Lengyel S, Tassonyi E.
    Eur J Anaesthesiol; 2017 Sep 01; 34(9):609-616. PubMed ID: 28030444
    [Abstract] [Full Text] [Related]

  • 26. Neuromuscular monitoring, reversal and postoperative residual neuromuscular block: An intradepartmental survey over the years.
    Cammu GV, Klewais LR, Vandeput DM, Foubert LA.
    Anaesth Intensive Care; 2020 Jan 01; 48(1):73-75. PubMed ID: 31979984
    [No Abstract] [Full Text] [Related]

  • 27. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review.
    Brinch JHW, Söderström CM, Gätke MR, Madsen MV.
    Acta Anaesthesiol Scand; 2019 May 01; 63(5):564-575. PubMed ID: 30548256
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ, Mirakhur RK, Kumar N.
    Can J Anaesth; 1996 Dec 01; 43(12):1220-3. PubMed ID: 8955970
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog.
    Martin-Flores M, Boesch J, Campoy L, Gleed RD.
    J Am Anim Hosp Assoc; 2011 Dec 01; 47(4):294-8. PubMed ID: 21673340
    [Abstract] [Full Text] [Related]

  • 32. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B, Sasaki N, Grobara P, Li MK, Woo T, de Bie J, Maktabi M, Lee J, Kwo J, Pino R, Sabouri AS, McGovern F, Staehr-Rye AK, Eikermann M.
    Br J Anaesth; 2015 Nov 01; 115(5):743-51. PubMed ID: 25935840
    [Abstract] [Full Text] [Related]

  • 33. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
    Gaszynski T, Szewczyk T, Gaszynski W.
    Br J Anaesth; 2012 Feb 01; 108(2):236-9. PubMed ID: 22012861
    [Abstract] [Full Text] [Related]

  • 34. The influence of mild hypothermia on the pharmacokinetics and time course of action of neostigmine in anesthetized volunteers.
    Heier T, Clough D, Wright PM, Sharma ML, Sessler DI, Caldwell JE.
    Anesthesiology; 2002 Jul 01; 97(1):90-5. PubMed ID: 12131108
    [Abstract] [Full Text] [Related]

  • 35. Recovery of train-of-four ratio to 0.70 and 0.90 is delayed in type 2 diabetes with vecuronium-induced neuromuscular block.
    Nitahara K, Sugi Y, Shigematsu K, Haraga I, Abe S, Higa K.
    Eur J Anaesthesiol; 2013 Feb 01; 30(2):80-4. PubMed ID: 23172246
    [Abstract] [Full Text] [Related]

  • 36. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
    Dahaba AA, Bornemann H, Hopfgartner E, Ohran M, Kocher K, Liebmann M, Wilfinger G, Metzler H.
    Br J Anaesth; 2012 Apr 01; 108(4):602-6. PubMed ID: 22315331
    [Abstract] [Full Text] [Related]

  • 37. Prolonged mivacurium-induced neuromuscular block. Case report.
    Arcioni R, Sanfilippo M, Romano R, Lappa A, Mercieri M, Müller TM, Marcotullio D.
    Minerva Anestesiol; 1999 Oct 01; 65(10):737-9; discussion 740. PubMed ID: 10598432
    [Abstract] [Full Text] [Related]

  • 38. Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial.
    Asztalos L, Szabó-Maák Z, Gajdos A, Nemes R, Pongrácz A, Lengyel S, Fülesdi B, Tassonyi E.
    Anesthesiology; 2017 Sep 01; 127(3):441-449. PubMed ID: 28640017
    [Abstract] [Full Text] [Related]

  • 39. Observational study on patterns of neuromuscular blockade reversal.
    Dubovoy T, Housey M, Devine S, Kheterpal S.
    BMC Anesthesiol; 2016 Oct 22; 16(1):103. PubMed ID: 27770778
    [Abstract] [Full Text] [Related]

  • 40. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
    Blobner M, Busley R, Mann R, Jelen-Esselborn S, Kochs E.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct 22; 34(10):638-41. PubMed ID: 10548961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.